Top Sell
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | €0.39 | - | - |
| Promis Neurosciences Inc. | 0 | 1 | 0 | 0 | €1.34 | €1.20 | -10.448% |
| Chimerix Inc. | 3 | 1 | 0 | 0 | €0.83 | €5.51 | 568.436% |
| Biofrontera AG | 0 | 1 | 0 | 0 | €0.33 | - | - |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.26 | - | - |
| Medigene AG | 1 | 1 | 0 | 0 | €1.16 | - | - |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | €0.34 | €21.06 | 6072.333% |
| Innate Pharma | 0 | 1 | 0 | 1 | €2.05 | - | - |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.31 | €50.00 | 3725.555% |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €1.28 | - | - |
| Inventiva SA | 1 | 1 | 0 | 1 | €2.21 | €6.00 | 171.493% |
| B.R.A.I.N. Biotechnology Research and Information Network AG | 0 | 1 | 0 | 0 | €2.19 | - | - |
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €5.40 | - | - |
| Agenus Inc. | 4 | 2 | 0 | 0 | €0.41 | €37.02 | 8846.834% |
| Protalix Biotherapeutics Inc. | 1 | 2 | 0 | 0 | €1.04 | €2.00 | 92.400% |
| Gritstone Oncology Inc | 4 | 2 | 0 | 0 | €0.59 | €5.07 | 763.118% |
| Coherus Bioscien. | 1 | 2 | 0 | 0 | €1.52 | - | - |
| Glycomimetics Inc. | 5 | 3 | 0 | 1 | €0.21 | €7.35 | 3400.762% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.37 | €3.00 | 716.549% |
| Cara Therapeutics Inc. | 11 | 4 | 0 | 2 | €0.33 | €4.62 | 1287.688% |
| Organovo Holdings Inc. | 0 | 8 | 0 | 1 | €0.52 | - | - |
| Minerva Neurosciences Inc. | 0 | 9 | 0 | 3 | €2.92 | - | - |
| Neptune Wellness Solutions Inc | 0 | 11 | 0 | 0 | €0.14 | - | - |
| Bellicum Pharmaceuticals Inc. | 0 | 12 | 0 | 0 | €0.064 | - | - |
| Trevena Inc. | 2 | 20 | 0 | 2 | €0.18 | €6.48 | 3521.229% |